Aristides Capital LLC Co Diagnostics, Inc. Transaction History

Aristides Capital LLC

  • $219 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
SELL
$2.87 - $7.01 $129,150 - $315,450
-45,000 Reduced 75.0%
15,000 $48,000
Q1 2022

May 16, 2022
SELL
$5.03 - $9.61 $84,001 - $160,487
-16,700 Reduced 21.77%
60,000 $371,000
Q4 2021

Feb 14, 2022
BUY
$8.12 - $10.37 $622,803 - $795,378
76,700 New
76,700 $685,000

Others Institutions Holding CODX

# of Institutions
43
Shares Held
4.3M
Call Options Held
48.2K
Put Options Held
53.3K
View Full List

About Co-Diagnostics, Inc.

CODX Quotes by TradingView
  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $35.8M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Aristides Capital LLC Portfolio

Follow Aristides Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristides Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email